Multimodal feature fusion model for breast mass malignant risk stratification - Summary - MDSpire

Multimodal feature fusion model for breast mass malignant risk stratification

  • By

  • Shengxin Pei

  • Xiumei Tang

  • Hongxia Su

  • Jingyan Liu

  • Zihan Lan

  • Siyu Wang

  • Yulan Peng

  • June 3, 2026

  • 0 min

Share

Objective:

Emphasize the significance of integrating multimodal features for improved risk stratification.

Key Findings:
  • Include confidence intervals for AUC values.
Interpretation:

Expand on the implications of the findings for clinical practice.

Limitations:
  • Specify how the single-center study affects generalizability.
Conclusion:

Reiterate the need for multicenter validation more prominently.

Original Source(s)

Multimodal feature fusion model for breast mass malignant risk stratification

  • by Shengxin Pei, Xiumei Tang, Hongxia Su, Jingyan Liu, Zihan Lan, Siyu Wang, Yulan Peng

  • June 3, 2026

Related Content

Chemoradiation after chemotherapy for metastatic cervical cancer can provide chemo-free time

HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature